Table 2.
Term | Count | P Value* | Genes |
---|---|---|---|
PIRSF001733: tripartite motif-containing protein | 7 | 1.99E-07 | TRIM5, TRIM34, TRIM50, TRIM26, TRIM21, TRIM74, TRIM73 |
GO: 0019882~antigen processing and presentation | 11 | 1.21E-06 | HLA-H, PSME1, TAP2, CD209, ERAP1, ERAP2, TAPBPL, PSMB8, TAPBP, PSMB9, B2M |
IPR007904: APOBEC-like, C-terminal | 5 | 1.45E-05 | APOBEC3B, APOBEC3G, APOBEC3F, APOBEC3C, APOBEC3D |
GO: 0006955~immune response | 28 | 3.64E-05 | OAS3, TLR3, APOBEC3G, IL15, APOBEC3F, IFI35, B2M, TAPBP, FCGR1C, TAP2, TAP1, ERAP1, ERAP2, DHX58, HLA-H, BST2, IL29, TNFRSF14, PSMB8, PSMB9, IL18BP, APOL1, TNFSF13B, PSEN1, ETS1, CD209, CD274, GBP1 |
IPR012317: Poly(ADP-ribose) polymerase, catalytic region | 5 | 1.50E-04 | PARP9, PARP14, PARP3, PARP10, PARP4 |
IPR008405: Apolipoprotein L | 4 | 1.51E-04 | APOL2, APOL1, APOL6, APOL4 |
Host-virus interaction | 15 | 1.89E-04 | HAVCR1, CCNT1, TNFRSF14, APOBEC3G, SP110, APOBEC3F, PSMB8, APOBEC3C, PSMB9, TRIM5, ISG15, TAP2, CD209, TAP1, RBCK1 |
The p values represent the significance of gene enrichment using all known human genes as background.